Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T20:37:20.822Z.
Calculation as of: 2026-10-06T20:37:20.822Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fb4a8502ebbb15e11e68a15a33f7d53c7b5c9812bb79594c7d74d11368e8432a
EARNINGS YIELD
N/A
Milestone Pharmaceuticals Inc.
Market Cap
$95.14M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$93.96M
Earnings Yield
N/A
TTM Avg
7.66%
3Y Avg
7.66%
5Y Avg
7.66%
Market Cap
$90.64M
Earnings Yield
45.67%
TTM Avg
46.30%
3Y Avg
46.30%
5Y Avg
46.30%
Market Cap
$90.20M
Earnings Yield
0.85%
TTM Avg
3.26%
3Y Avg
3.22%
5Y Avg
1.83%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $95.14M | N/A | N/A | N/A | N/A |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.96M | N/A | 7.66% | 7.66% | 7.66% |
| Korro Bio, Inc. (KRRO)vs › | $97.14M | N/A | N/A | N/A | N/A |
| PolyPid Ltd. (PYPD)vs › | $97.90M | N/A | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $97.94M | N/A | N/A | N/A | N/A |
| OnKure Therapeutics, Inc. (OKUR)vs › | $99.62M | N/A | N/A | N/A | N/A |
| Rallybio Corporation (RLYB)vs › | $90.64M | 45.67% | 46.30% | 46.30% | 46.30% |
| Biomea Fusion, Inc. (BMEA)vs › | $90.37M | N/A | N/A | N/A | N/A |
| ImmuCell Corporation (ICCC)vs › | $90.20M | 0.85% | 3.26% | 3.22% | 1.83% |
| Equillium, Inc. (EQ)vs › | $89.78M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
